Pharmacokinetics, Safety, and Tolerability Study of the Pen and PFS of SB5 in Healthy Subjects

NCT02326233 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
190
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Samsung Bioepis Co., Ltd.